IncellDx | GenomeWeb


Single-cell RNA sequencing on thousands of tumor and surrounding cells from 19 melanoma samples revealed subsets of cells with apparent resistance potential.

IncellDx's investigational molecular assay used to quantify HPV E6/E7 mRNA in single cells has been optimized to run on Beckman Coulter's CytoFlex flow cytometry system.

The partners will couple Claremont BioSolutions' enzyme-free tissue homogenization technology with IncellDx's reagents.

IncellDx said this week that it has hired Christine Meda as chief business officer.

Former Life Technologies executive Paul Grossman has joined Telegraph Hill Partners as a venture partner.

NEW YORK (GenomeWeb News) – IncellDx and Bristol-Myers Squibb have signed an agreement to develop a molecular test that may eventually be used as a companion diagnostic to identify best responders to an investigational drug in BMS's pipeline.

NEW YORK (GenomeWeb News) – IncellDx today said it has reached a deal to offer its molecular diagnostic test for human papillomavirus in India.

NEW YORK (GenomeWeb News) – Molecular diagnostics company IncellDx today announced a deal with Chinese esoteric reference laboratory Kindstar Global to offer IncellDx's test for detecting oncogenic human papillomavirus PV E6, E7 messenger RNA in China.

This article has been corrected to note that the OncoTect 3Dx technology is slideless and the sample size for the study is 10,000 rather than the previously stated 100,000.

BRL launches InCellDx's HPV mRNA Test
Bio-Reference Laboratories announced this week that its GenPath Women's Health division has launched a new test called GenCerv.


In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.